Real-world predictors of 12–month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study

by Xavier Mariette, Alain Cantagrel, Rieke Alten, Manuela Le Bars, Yedid Elbez, Hanns-Martin Lorenz, Mauro Galeazzi, Hubert G Nüßlein, Melanie Chartier, Christiane Rauch
Published 2017-12-01